Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Mangoceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −1 vs. Q4 2024
- Shares held
- 75.3K
- −16.0K (−17.5%) vs. Q4 2024
- Total value
- $146.9K
- −$74.1K (−33.5%) vs. Q4 2024
- New holders
- 1
- 4 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $455.6K |
| Q1 2026 | 18 | $297.6K |
| Q4 2025 | 18 | $1.88M |
| Q3 2025 | 11 | $820.1K |
| Q2 2025 | 10 | $444.2K |
| Q1 2025 | 8 | $146.9K |
| Q4 2024 | 9 | $220.9K |
| Q3 2024 | 13 | $319.7K |
| Q2 2024 | 6 | $147.7K |
| Q1 2024 | 8 | $72.0K |
| Q4 2023 | 5 | $34.9K |
| Q3 2023 | 9 | $135.8K |
| Q2 2023 | 5 | $166.4K |
| Q1 2023 | 1 | $5.32K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Mangoceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ackerman Capital Advisors, LLC | 34,500 | $67.3K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,570 | $38.2K | 0.00% | +7,567+63.0% | Added |
| UBS Group AG | 7,510 | $14.6K | 0.00% | +5,986+392.8% | Added |
| Federation des caisses Desjardins du Quebec | 7,100 | $13.8K | 0.00% | +2,500+54.3% | Added |
| Advisor Group Holdings, Inc. | 2,885 | $5.63K | 0.00% | +2,885 | New |
| Steward Partners Investment Advisory, LLC | 2,094 | $4.08K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,643 | $3.20K | 0.00% | −990−37.6% | Reduced |
| Bank of America Corp | 15 | $29 | 0.00% | +4+36.4% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,501−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,472−100.0% | Sold out |